|
Hyundai Pharmaceutical Company Limited - Company Profile Snapshot
| Company Profile: |
Hyundai Pharmaceutical Company Limited |
| Ticker: |
004310 |
| Exchanges: |
SEO |
| 2008 Sales: |
120,520,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
KOREA (SOUTH) |
| Employees: |
507 |
Business Description
Hyundai Pharmaceutical Company Limited Formerly known as Hyundai Pharmaceutical Industrial Company Limited. The Company's principal activity is manufacturing of pharmaceutical products. The Company's main medical products include Tenormin tablets, for hypertension and angina pectoris; Zestril tablets, for hypertension and congest heart failure; Elroton tablets, for coronary artery diseases; Surfolase capsules, for acute or chronic respiratory diseases resulting from respiratory obstruction and disturbance in mucous secretion and Norlevo tablets, for oral emergency contraceptives.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
